Pharmaron

Pharmaron

制药业

Premier life science service provider

关于我们

Pharmaron (Stock Code: 300759.SZ/3759.HK) is a premier service provider for the life sciences industry. Founded in 2004, Pharmaron has invested in its people and facilities, and established a broad spectrum of research, development and manufacturing service capabilities throughout the entire drug discovery, preclinical and clinical development process across multiple therapeutic modalities, including small molecules, biologics and CGT products. With over 20,000 employees and operations in China, the U.S., and the U.K., Pharmaron has an excellent track record in the delivery of R&D solutions to its partners in North America, Europe, Japan and China. Services: * Synthetic, medicinal and analytical chemistry services * Biology services * DMPK services * Pharmacology services * Drug safety assessment services * Radiochemistry and isotopically labelled metabolism services * Chemical & pharmaceutical development services * Clinical development services www.pharmaron.com CRO - Contract Research Organization & CDMO - Contract Development Manufacturing Organization Library Synthesis CADD Bioorganic Chemistry Discovery Process Chemistry Radiolabelled Chemical Synthesis ChemInformatics in vitro Biology in vitro Screening Structural Biology in vivo Pharmacology Animal Disease Models ex vivo Pharmacology Biomarkers in vitro ADME in vivo PK PKPD QA Regulatory Affairs Discovery Biologics Process Chemistry API Manufacturing Material Science Formulation Development Drug Product Manufacturing Toxicology Safety Pharmacology Genetic Toxicology DART Pathology Immunotoxicity Bioanalytical 14C / Carbon-14 Radiosynthesis 3H / Tritium Radiosynthesis QWBA mARG Clinical AME Mass Balance Metabolite Profiling Microdosing Phase 0 Absolute Bioavailability DDI First-in-Human (FIH) Thorough QT(TQT) Ethnobridging

所属行业
制药业
规模
超过 10,001 人
总部
Beijing
类型
私人持股
领域
Chemistry、Biology、DMPK、Pharmacology、Chemical Development、Preclinical、Toxicology、Safety Pharmacology、Discovery、Lead Optimization、Process Development、Assay Development、ADME、Formulation、clinical pharmacology、analytical sciences、radiolabelled chemistry、accelerator mass spectrometry、radiolabelled compounds、API manufacturing、radiosynthesis、Biologics和CTG Products

地点

  • 主要

    6 Taihe Road

    BDA

    CN,Beijing,100176

    获取路线
  • 201 East Jefferson Street

    US,KY,Louisville,40202

    获取路线
  • 404 Wyman St

    Suite 365

    US,Massachusetts,Waltham,02451

    获取路线
  • 800 West Baltimore St

    US,MD,Baltimore,21201

    获取路线
  • 20340 Seneca Meadows Pkwy

    US,Maryland,Germantown,20876

    获取路线
  • Hertford Road

    GB,Herfordshire,Hoddesdon,EN11 9BU

    获取路线
  • The Old Glassworks, Nettlefold Road

    GB,England,Cardiff,CF24 5JQ

    获取路线
  • Pegasus Way, Crown Business Park

    GB,Northampshire,Rushden,NN10 6ER

    获取路线

Pharmaron员工

动态

关联主页

相似主页

融资

Pharmaron 共 4 轮

上一轮

上市后股权

US$587,815,480.00

Crunchbase 上查看更多信息